LSERS
LGND icon

Louisiana State Employees Retirement System’s Ligand Pharmaceuticals LGND Stock Holding History

Louisiana State Employees Retirement System’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Buy
8,800
+100
+1% +$23.6K 0.04% 454
2026
Q1 		$1.74M Sell
8,700
-300
-3% -$59.4K 0.03% 630
2025
Q4 		$1.7M Hold
9,000
– – 0.03% 638
2025
Q3 		$1.59M Hold
9,000
– – 0.03% 698
2025
Q2 		$1.02M Buy
9,000
+100
+1% +$10.7K 0.02% 961
2025
Q1 		$936K Sell
8,900
-200
-2% -$22.6K 0.02% 1006
2024
Q4 		$975K Buy
9,100
+300
+3% +$33.9K 0.02% 1020
2024
Q3 		$881K Buy
8,800
+300
+4% +$30.2K 0.02% 1106
2024
Q2 		$716K Buy
8,500
+400
+5% +$31.8K 0.01% 1181
2024
Q1 		$592K Sell
8,100
-100
-1% -$7.37K 0.01% 1278
2023
Q4 		$586K Sell
8,200
-100
-1% -$5.9K 0.01% 1279
2023
Q3 		$497K Sell
8,300
-300
-3% -$19.7K 0.01% 1292
2023
Q2 		$620K Buy
8,600
+1,100
+15% +$82.5K 0.01% 1212
2023
Q1 		$552K Sell
7,500
-100
-1% -$7.11K 0.01% 1201
2022
Q4 		$508K Sell
7,600
-4,743
-38% -$308K 0.01% 1227
2022
Q3 		$663K Sell
12,343
-802
-6% -$47.1K 0.02% 1018
2022
Q2 		$765K Buy
13,145
+161
+1% +$9.14K 0.02% 995
2022
Q1 		$832K Hold
12,984
– – 0.02% 1019
2021
Q4 		$1.25M Buy
12,984
+160
+1% +$14.8K 0.03% 757
2021
Q3 		$1.11M Buy
12,824
+5,931
+86% +$459K 0.03% 790
2021
Q2 		$564K Hold
6,893
– – 0.01% 1226
2021
Q1 		$656K Buy
6,893
+481
+8% +$45.5K 0.02% 1133
2020
Q4 		$398K Hold
6,412
– – 0.01% 1286
2020
Q3 		$381K Hold
6,412
– – 0.02% 1134
2020
Q2 		$447K Hold
6,412
– – 0.03% 847
2020
Q1 		$291K Sell
6,412
-321
-5% -$18.2K 0.02% 947
2019
Q4 		$438K Sell
6,733
-641
-9% -$42.8K 0.02% 1070
2019
Q3 		$458K Sell
7,374
-641
-8% -$40.2K 0.02% 1011
2019
Q2 		$580K Sell
8,015
-802
-9% -$59.1K 0.03% 887
2019
Q1 		$691K Sell
8,817
-160
-2% -$12.1K 0.03% 772
2018
Q4 		$760K Sell
8,977
-5,931
-40% -$632K 0.04% 616
2018
Q3 		$2.55M Sell
14,908
-321
-2% -$48.4K 0.11% 158
2018
Q2 		$1.97M Buy
15,229
+161
+1% +$18K 0.09% 207
2018
Q1 		$1.55M Buy
15,068
+481
+3% +$47.6K 0.07% 301
2017
Q4 		$1.25M Buy
14,587
+961
+7% +$83.3K 0.06% 428
2017
Q3 		$1.16M Buy
13,626
+1,123
+9% +$88.9K 0.05% 462
2017
Q2 		$947K Buy
12,503
+160
+1% +$11.2K 0.05% 567
2017
Q1 		$815K Buy
12,343
+160
+1% +$10.5K 0.04% 673
2016
Q4 		$772K Sell
12,183
-1,282
-10% -$80.9K 0.04% 699
2016
Q3 		$857K Hold
13,465
– – 0.05% 587
2016
Q2 		$1M Buy
13,465
+641
+5% +$47.6K 0.05% 466
2016
Q1 		$857K Hold
12,824
– – 0.04% 593
2015
Q4 		$867K Hold
12,824
– – 0.04% 580
2015
Q3 		$685K Buy
12,824
+160
+1% +$9.71K 0.04% 764
2015
Q2 		$797K Buy
12,664
+161
+1% +$8.78K 0.04% 713
2015
Q1 		$601K Sell
12,503
-1,123
-8% -$43K 0.03% 933
2014
Q4 		$452K Sell
13,626
-320
-2% -$10.4K 0.02% 1141
2014
Q3 		$409K Sell
13,946
-1,443
-9% -$47.9K 0.02% 1152
2014
Q2 		$598K Hold
15,389
– – 0.03% 954
2014
Q1 		$646K Buy
15,389
+321
+2% +$13.4K 0.03% 879
2013
Q4 		$494K Buy
+15,068
New +$491K 0.02% 1060

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Louisiana State Employees Retirement System's LGND Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Ligand Pharmaceuticals (LGND) stake by 1.1% in Q2 2026, buying an estimated $23.6K and bringing the position to 8,800 shares worth $2.78M. The position accounts for 0.04% of the portfolio, ranked #454.

Louisiana State Employees Retirement System first reported a position in LGND in Q4 2013 and has held it in 51 quarters since. 115 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Louisiana State Employees Retirement System held 8,800 shares of Ligand Pharmaceuticals worth $2.78M as of Q2 2026.
  • Louisiana State Employees Retirement System bought 100 Ligand Pharmaceuticals shares in Q2 2026, an estimated $23.6K.
  • Ligand Pharmaceuticals made up 0.04% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #454 holding.
  • Louisiana State Employees Retirement System first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • 115 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.